Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Brooklynjack on Mar 20, 2019 6:11pm

42 Views

Post# 29513812

RE:Why would anyone listen to these Stockhouse basher goofs?

That is just it. They are pieces of dirt who have nothing better to do. All bashers go on ignore. Who the fk has enough time to sit at home and bash a stock they don’t own?? That is some real desperate need for attention sht. Get a life, get a wife….enjoy your time here.
If you don’t own it NF then pis off. If you do own NF and you don’t like it either sell or add constructive thought. This is the sht that drives me away from Stockhouse….think it is time for a break

Bullboard Posts

Global Tungsten Market and Supply Security